I am a
Home I AM A Search Login

Papers of the Week

2022 Jan 28

J Cutan Med Surg

Onset of Symptom Relief Reported in Daily Diaries in Patients With Atopic Dermatitis Treated With Baricitinib in a United States Clinical Trial (BREEZE-AD5).


Rosmarin D, Casillas M, Chen S, Dawson Z, Pierce E, Zhang H, Bukhalo M, Smith S
J Cutan Med Surg. 2022 Jan 28:12034754211073661.
PMID: 35086348.


Itch and sleep disturbance due to itch are burdensome symptoms associated with atopic dermatitis (AD). Rapid onset of action is important for AD treatments to improve quality of life and relieve suffering.